Michael W. Bishop, MD, MS
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael W. Bishop, MD, MS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03006848 · A Phase II Trial of Avelumab in Patients With Recurrent or Progressive OsteosarcomaSt. Jude Children's Research Hospital · completed · Osteosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 86 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Gene-pesticide interactions and ADHDR01ES032270 · NIEHS · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2020 to 2024 · $433,884 awarded in 2024Same name and institution; not confirmed by an ID
- Informing Policies to Address Childhood Obesity: A Systems ApproachP20GM109096 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · fiscal years 2016 to 2018 · $122,530 awarded in 2018Same name and institution; not confirmed by an ID
- Effect of Lead, Manganese and Stress During DevelopmentR01ES015689 · NIEHS · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2006 to 2010 · $353,274 awarded in 2010Same name and institution; not confirmed by an ID
- Developmental Interactions of methamphetamine and stressK01DA014269 · NIDA · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2002 to 2006 · $116,726 awarded in 2006Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in osteosarcoma.